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Editorial Comment
What We Can't Explain Can
Hurt Us and Our Patients
SUZANNE B. KNOEBEL, MD, FACC
Indianapolis, Indiana
The report in this issue of the Journal, entitled "Cost-Ef-
fective Analysis of Patient Management Alternatives After
Uncomplicated Myocardial Infarction: A Model," (I) de-
scribes the first cost-effectiveness analysis sponsored by the
American College of Cardiology. The initiative was devel-
oped in response to increasing pressures being placed on
the subspecialty and, hence, the College to provide the
criteria for quality care and, more explicitly, effective and
efficient care coupled with due regard for the cost of such
care,
"Surrogate" standards. Traditionally, quality care and
technology assessment and assurances have been based on
standards relative to the structural elements and processes
of care thought to lead to optimal patient outcome, although
it has been recognized that there may be tittle correlation
among structure, process and outcome (2). In the absence
of direct causal links between the structure and process of
care and a change in health status or decreased risk for
future cardiovascular events attributable to the intervention
of health care providers, the concept of surrogate outcome
values-an example might be the treatment of hypertension
as a surrogate outcome value for the prevention of cerebro-
vascular accidents-presumably provides the justification
for most "standards" formulations, In addition, if the links
between process and outcome could be definitively estab-
lished for the majority of the major cardiovascular diseases,
standards of care based on surrogate outcome criteria might
be acceptable instruments, in many instances, to address
the effectiveness component of the quality care totality (2).
However, even valid surrogate "standards" still would not
allow any quantitative evaluation of the overall significance
of any specific surrogate process relative to other interven-
tions that also might result in a salutary patient outcome-
might prevent cerebrovascular accidents, for example-and,
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thus, do not address the efficiency and cost components of
the quality care equation. Standards of care do not permit
comparisons between alternative strategies and do not pro-
vide information on which to base decisions relative to un-
der- or overutilization of technologies. Indeed, standards of
care may encourage overutilization by pointing out the ef-
ficacy of diverse technologies for the same patient problem.
Redundant testing without an understanding of the incre-
ment of certainty about a patient to be gained from each
test cannot be rationally justified or condemned and "stan-
dards" do not provide that understanding.
Guidelines versus standards or rules. There are other
problems and risks with "standards," To nonphysicians,
the term' .standard" generaII y means a rule. A rule connotes
a precise measure of quality, weight, extent or value. The
implication is that of absolute right or wrong. To the phy-
sician, a "standard" generally means a model or set of
guidelines providing general consensus on the appropriate-
ness of technology utilization management alternatives.
Shades of gray are recognized, allowed and even encouraged
in order that medical progress not be stifled. It has been the
experience, however, that conversion of guidelines to rules
usually is rapidly accomplished by third party payers or
purchasers of health care as rule-based criteria are relatively
easy to check for compliance. It might be predicted that this
conversion will accelerate as patient data and individual
physician practice patterns are increasingly available in
computer data banks as a by-product of cost control pro-
cesses. If standards of care for the management of the patient
after myocardial infarction were set forth, for example, third
party payers might decide not to reimburse for a test or
therapy, or a physician might be judged to be an "expen-
sive" physician because technologies were used or therapies
instituted that were not mentioned in the standards. Another
example is that a review organization might "rule" that all
patients must have a specific test or therapy recommended
in the guidelines and declare that an intrusion on quality
care occurred because the rule was not followed. It is par-
tially because of this potential misuse of guidelines that most
standards emanating from professional societies carry a great
number of "mayor may not be indicated" or "these guide-
lines should be modified according to individual circum-
stances" statements.
Validating or invalidating recommendations for the
individual patient. When all appropriate caveats are in-
cluded, standards of care become only broadly relevant but,
at the same time. provide no recourse to the physician caring
for the individual patient or to the profession as it attempts
to assure effective care. Because standards are nonquanti-
tative instruments, reimbursement or resource allocation de-
cisions cannot be readily challenged on the basis of irrel-
evance to individual patient needs. Standards are derived
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from the experience with large homogeneous patient groups
and are based on expert consensus about such groups. The
individual patient represents a multidimensional problem,
the most significant deterministic components of which may
be unique or interactive in ways not represented in the pa-
tient group from which the standards were derived. The
process of diagnosis and management strategy formulation
for the individual patient does not evolve by first finding a
disease and then fitting the patient into the pattern of that
disease, ignoring the features that are discordant. Rather,
features are collected and a pattern is built up and matched
with patterns of disease from the physician's experience and
knowledge base. The discordant features are maintained as
a part of the individual pattern, and they retain importance
as the process of care and outcomes develop (3). These
individual variations cannot be quantitatively assessed for
importance relative to validating or invalidating the rec-
ommendations for such patients under standards of care.
Decision analysis: an approach to effective medical
care. The approach of Dittus, Roberts and Adolph (I) is
based on decision analysis which, when fully developed,
may obviate many of the problems related to standards of
care. Decision analysis permits the construction of an ex-
plicit, mathematically describable model of a clinical prob-
lem, the details of which can vary according to the purpose
for which the individual analysis is undertaken (4). The goal
is optimal patient outcome. The model describing alternative
approaches to care of the patient after uncomplicated myo-
cardial infarction, although not intended to be definitive,
provides several important insights into the power of the
technique: the relative effectiveness of alternative ap-
proaches to care can be identified; costly practices become
apparent; new technologies can be placed in relation to the
old in terms of effectiveness and cost; and the marginal
benefit to be achieved by duplicative or alternative practices
or therapies can be assessed. All of this can be accomplished
in terms of patient outcome and without the bias and self-
interest of which the profession has been accused.
Of penultimate importance is the fact that decision anal-
ysis facilitates explanations in quantifiable terms of why it
is physicians do what they do. If patients are to be asked
to give up the type of care to which they are accustomed
in the name of cost, it is only fair that they have the infor-
mation presented in understandable terms as to what it is
they are giving up in terms of effectiveness. If a resource
allocation, reimbursement or practice pattern decision is
made in the name of cost containment that eliminates or
limits access to effective technology or subspecialty care,
the impact of that decision on effective care can be explicitly
and quantitatively expressed. Based in terms of effective
patient outcome, such demonstrations become difficult to
ignore. Protestations based on claims of infringement on
"quality" care as expressed in "standards," however, are
often dismissed as being self-serving, and there is no good
defense against that opinion.
In addition to the socioeconomic advantages of decision
analysis, individual patient care also may benefit from well
structured analyses. To the extent that an individual patient
is similar to the patients described in a model and to the
extent that the model captures the relevant clinical features,
a published analysis can be utilized in clinical decision-
making, but without being prescriptive or restrictive. If the
model does not "match" all of the considerations that the
physician deems to be of importance for the individual pa-
tient, the model still remains useful through a reduction in
the number of alternatives to be considered. Also, the phy-
sician is forced to explicitly acknowledge and address those
aspects of the decision that the model includes. Why was
this approach included? Why was subgrouping by ventric-
ular function done? Without such prompting, significant
deterministic components of an individual patient's problem
might be overlooked. To be most useful, the model should
permit the physician to interact with it, testing varying prob-
abilities as to their most likely effect on individual patient
outcome.
Future directions. The American College of Cardiology
is taking the lead among professional clinical societies in
exploring decision analysis as a method to explain and often
defend cardiovascular practices and technologies in terms
of their efficiency, effectiveness and cost; and, through fo-
cusing on the effectiveness component of the quality of care,
is serving as a responsible patient advocate. It is only a
beginning, however. To achieve optimal benefit from and
acceptability for decision analysis, the models must be data
driven. The baseline characteristics that have deterministic
importance with and without therapy need to be known so
that the models are precisely constructed. Outcome values
must accurately reflect the effects of interventions. If out-
come values are widely disparate without a difference in
baseline clinical characteristics, it may be necessary to look
back into the process of care (2). This analytic capability
must be provided for. The models must be structured and
maintained so that constant ongoing revision is feasible.
The computer and data base management techniques are
now available to construct and maintain data-driven decision
analyses (5). This was not true a decade ago. It is important
that the advantages they offer become incorporated into
quality care assessment. Understanding enables coherent
explanation; coherent explanation enables effective advo-
cacy.
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